News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
140 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2946)
February (2976)
March (2714)
April (2913)
May (3639)
June (2347)
Day
1 (184)
2 (144)
5 (162)
6 (107)
7 (309)
8 (243)
9 (171)
12 (212)
13 (134)
14 (258)
15 (267)
16 (110)
19 (118)
20 (147)
21 (149)
22 (140)
23 (133)
26 (20)
27 (148)
28 (183)
29 (192)
30 (107)
31 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
Day
1
2
5
6
7
8
9
12
13
14
15
16
19
20
21
22
23
26
27
28
29
30
31
Mergers & acquisitions
Sanofi Buys Vigil for $470M Upfront, Reigniting a Battered Alzheimer’s Target
The deal helps revitalize the TREM2 target after the high-profile failure of AbbVie and Alector’s candidate last year.
May 22, 2025
·
4 min read
·
Annalee Armstrong
Adcomms
Pfizer’s Talzenna Expansion Fails To Earn FDA Advisory Committee’s Support
The FDA’s independent advisors found Pfizer’s data lacked the precision needed to establish the efficacy of Talzenna in patients with prostate cancer who do not carry HRR mutations.
May 22, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
‘We Don’t Believe This Is Right’: Lilly Bristles as CMS Leaves Obesity Drugs Out of Medicare
The CMS last month declined to include anti-obesity medications in its Medicare coverage for Part D, a move that Lilly says could interfere with patients getting the appropriate medical care.
May 22, 2025
·
2 min read
·
Tristan Manalac
Job Trends
Exit Strategy: Biopharma Pros Look Outside Industry—and US
A
BioSpace
survey found that 56% of employed and 81% of unemployed respondents are considering jobs outside biopharma. Some are also seriously thinking about leaving the U.S. to find employment in the field.
May 22, 2025
·
6 min read
·
Angela Gabriel
IN PARTNERSHIP WITH IQVIA
How Target Product Profiles Guide the Industry Through Uncertain Times
In this episode presented by IQVIA, BioSpace’s head of insights Lori Ellis discusses the importance of target product profiles, particularly when navigating funding challenges, with Ian Fisher, head of development analytics.
May 22, 2025
·
1 min read
·
Lori Ellis
Job Trends
11 Companies Hiring Manufacturing Professionals
Looking for a manufacturing job? Check out the
BioSpace
list of 11 companies hiring life sciences professionals like you.
May 22, 2025
·
2 min read
·
Angela Gabriel
Business
Southeast’s Life Sciences Scene Heats Up With Job, Business Growth
Nine states in the Southeast showed growth in bioscience employment and establishments from 2019 to 2023, according to 2024 data from BIO and TEConomy Partners. NCBiotech and Bexion executives discuss the area and the pros and cons of setting up shop far from major hubs.
May 22, 2025
·
6 min read
·
Angela Gabriel
Vaccines
FDA Asks Pfizer/BioNTech, Moderna To Add Myocarditis Risk to COVID-19 Vaccines
The FDA had given Pfizer and Moderna until May 17 to propose changes to the labels of their COVID-19 vaccines or challenge the agency’s directive. The products’ labels already include myocarditis warnings, albeit for different age groups.
May 22, 2025
·
2 min read
·
Tristan Manalac
Drug pricing
FDA Advances Drug Importation Plan as Canada Moves To Protect Its Supply
Canada’s health agency says it has been “taking all necessary action safeguard the drug supply and ensure Canadians have access to the prescription drugs they need.”
May 22, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Globally Recognized Expert in Rare Autoimmune Neurologic Diseases, Dr. Benjamin Greenberg, Joins Trethera Scientific Advisory Board
May 22, 2025
·
6 min read
1 of 14
Next